Chere M. Alvarez
About Chere M. Alvarez
Chere M. Alvarez is an Executive Assistant and Office Manager with extensive experience in the biotech and pharmaceutical industries. She has held various roles supporting C-level executives and liaising with key stakeholders, including Board Members and the FDA.
Current Role at Alpine Immune Sciences
Chere M. Alvarez serves as the Executive Assistant and Office Manager at Alpine Immune Sciences, Inc. since 2023. In this role, she is responsible for managing office operations and providing support to executives. Her position involves coordinating activities and acting as a liaison between various stakeholders within the organization.
Previous Experience in Biotech and Pharmaceutical Industries
Chere M. Alvarez has held multiple executive assistant roles in the biotech and pharmaceutical sectors. She worked at Global Blood Therapeutics from 2018 to 2019, Ultragenyx Pharmaceutical Inc. from 2014 to 2018, and Fate Therapeutics Inc. from 2022 to 2023. Her experience includes supporting C-level executives and managing office functions in both start-up and established companies.
Work History at Genentech and Other Companies
Chere M. Alvarez began her career in the biotech field at Genentech, where she worked as a Management Associate from 2012 to 2014. She later transitioned to Gracenote in 2011 for a brief period before joining Ultragenyx. After her tenure at Ultragenyx, she worked at Equillium, Inc. from 2019 to 2021, and Allogene Therapeutics in 2023.
Education and Professional Development
Chere M. Alvarez has been studying at Bryman College since 1999. Her educational background supports her extensive experience in administrative roles across various industries, particularly in biotech and pharmaceuticals.
Expertise in Executive Support and Liaison Roles
Chere M. Alvarez possesses extensive experience acting as a liaison with Board Members, Investors, Key Opinion Leaders, and the FDA. Her skills include managing communications and facilitating interactions between executives and external stakeholders, which enhances operational efficiency within the organizations she has worked for.